EHA 2019: Labour is the most frequent outcome in the European Leukaemia Net registry of patients with chronic myeloid leukaemia and pregnancy
Family planning is an important issue for the CML patients of childbearing potential, because they…
Browsing: Haematology
EHA 2019: Genomic evidence of residual disease in patients in remission prior to stem cell transplant; fate or opportunity for early intervention?
Acute myeloid leukaemia (AML) is a rare, highly fatal blood cancer. Allogeneic haematopoietic cell transplantation…
Study reports ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown…
Towards a safer treatment for leukaemia
An international team of researchers at VIB-KU Leuven, Belgium, the UK Dementia Institute and the…
Patterns of chronic lymphocytic leukaemia growth identified
In patients with chronic lymphocytic leukaemia (CLL), the rate of disease growth is apt to…
Recovery twice as hard for survivors of childhood acute lymphoblastic leukaemia
Nearly 90 per cent of children with acute lymphoblastic leukaemia (ALL) survive, yet the same…
Researchers pinpoint why lymphoma patients may become resistant to specific therapy
With more targeted therapies being approved each year for cancer, the development of drug resistance…
New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small…
Study of tagraxofusp reports 90 percent response rate for deadly blood cancer with no prior available therapies
An open-label, multi-cohort Phase II trial, led by investigators at The University of Texas MD…
The Leukaemia Atlas: researchers unveil proteins that signal disease
Only about one in four people diagnosed with acute myelogenous leukaemia (AML) survive five years…